Blood-based Nanoparticle-Enhanced Quaking-Induced Conversion (Nano-QuIC): inhibitor-resistant detection of seeding activity in patients diagnosed with …

PR Christenson, H Jeong, M Li, H Ahn… - Nano …, 2024 - ACS Publications
A hallmark of α-synucleinopathies (eg, Parkinson's disease) is the misfolding and
aggregation of α-synuclein in tissues and biological fluids. Protein amplification assays like …

Neuropathology meets chemical and genetic pathology head-on: a personal perspective

CL Masters - Pathology, 2024 - Elsevier
Medical science has made revolutionary discoveries around the nosology and aetiology of
the neurodegenerative diseases. Dementia is the second leading cause of death in …

[HTML][HTML] Whole blood transcriptome profile identifies motor neurone disease RNA biomarker signatures

S Kõks, K Rallmann, M Muldmaa… - Experimental …, 2025 - pmc.ncbi.nlm.nih.gov
Blood-based biomarkers for motor neuron disease are needed for better diagnosis,
progression prediction, and clinical trial monitoring. We used whole blood-derived total RNA …

The prion-like effect and prion-like protein targeting strategy in amyotrophic lateral sclerosis

Y Wenzhi, L Xiangyi, F Dongsheng - Heliyon, 2024 - cell.com
Pathological proteins in amyotrophic lateral sclerosis (ALS), such as superoxide dismutase
1, TAR DNA-binding protein 43, and fused in sarcoma, exhibit a prion-like pattern. All these …

Blood-based Nano-QuIC: Inhibitor-resistant Detection of Seeding Activity in Patients Diagnosed with Parkinson's Disease

PR Christenson, H Jeong, M Li, H Ahn, AM Schmeichel… - bioRxiv, 2023 - biorxiv.org
A hallmark of α-synucleinopathies including Parkinson's disease, dementia with Lewy
bodies, and multiple system atrophy, is the misfolding and aggregation of α-synuclein in …